Skip to content

Product information

Stugeron 25 mg
200
cinnarizine
0131219
9.78 / 10
Locked

Product properties

298-57-7
N07CA02
Janssen-Cilag
Tablet
BE000585
05413868106169
FD
Public
000585-02

Pharmacist Assessment

Normally available

This product has good current availability (score 9.78/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 30/04/2027.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 18 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 30/04/2027

Commercial reasons

Under evaluation
Available Active
Until 29/04/2027

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
25 mg
298-57-7
Excipient
158.8 mg
Excipient
15 mg
Excipient
2.5 mg

Additional information

Availability statistics

Available
0 days
2
0